| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/25/2003 | EP1320363A1 Lactone integrin antagonists |
| 06/25/2003 | EP1320362A1 Stabilised fibrate microparticles |
| 06/25/2003 | EP1320356A2 Preparation of vitamin emulsions and concentrates thereof |
| 06/25/2003 | EP1263470B1 METHOD FOR PRODUCING A COENZYME Q10 / $g(g)-CYCLODEXTRIN COMPLEX |
| 06/25/2003 | EP1224178B1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics |
| 06/25/2003 | EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 06/25/2003 | EP1169313B1 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/25/2003 | EP1140019B1 Aerosol formulations for buccal and pulmonary application |
| 06/25/2003 | EP1025125B1 Aggregates of human insulin derivatives |
| 06/25/2003 | EP1001942B1 Polyhydroxybutylpyrazines, their preparation and medicines containing them |
| 06/25/2003 | EP1000008B1 Novel thyroid receptor ligands and method |
| 06/25/2003 | EP0726074B1 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 06/25/2003 | CN1426470A Talaromyces emersonii beta-glucanases |
| 06/25/2003 | CN1426422A 修饰的bdnf Modified bdnf |
| 06/25/2003 | CN1426412A Novel compounds |
| 06/25/2003 | CN1426409A Inhibitors of dipeptidyl peptidase IV |
| 06/25/2003 | CN1426402A Novel stable crystal of thiazolidinedione derivative and process for producing same |
| 06/25/2003 | CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof |
| 06/25/2003 | CN1426395A Inhibitors of dipeptidyl peptidase IV |
| 06/25/2003 | CN1426394A Novel compounds |
| 06/25/2003 | CN1426393A Novel compounds |
| 06/25/2003 | CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same |
| 06/25/2003 | CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging |
| 06/25/2003 | CN1426299A Antihypertensives and pharmaceutical use |
| 06/25/2003 | CN1425661A Lactonization processing method in preparing Tating compounds |
| 06/25/2003 | CN1425464A Process for preparing oral insulin nano material |
| 06/25/2003 | CN1425462A Changqing tablet and its preparing method |
| 06/25/2003 | CN1425429A Blood sugar reducing tablet |
| 06/25/2003 | CN1425422A Medicine for curing diabetes and nephrosis and its preparing method |
| 06/25/2003 | CN1425421A Medicine for curing diabetes and its preparing method |
| 06/25/2003 | CN1425420A Medicine for curing fat liver of obesity and its preparing method |
| 06/25/2003 | CN1425396A Herbal medicine blood sugar reducing powder or tablet |
| 06/25/2003 | CN1425386A Dimethyl-sulfone sulfide supplementary agent and its overlapped health articles |
| 06/25/2003 | CN1425374A Composition for treating hyperlipemia |
| 06/25/2003 | CN1425372A Method for preparing nano linolenic acid emulsion |
| 06/25/2003 | CN1112367C Use of pharmaceutical composition comprising appetite-suppressing peptide |
| 06/25/2003 | CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF) |
| 06/25/2003 | CN1112356C Nitromethylthiobenzene derivative as inhibitors of aldose reductase |
| 06/25/2003 | CN1112214C Organic trace element supplement |
| 06/25/2003 | CN1112196C Medicine for regulating blood fat and reducing plasma fibrin |
| 06/25/2003 | CN1112187C Medicinal composition for treating diabetes |
| 06/25/2003 | CN1112186C Cerebral metabolism activator containing glucose ester derivative |
| 06/24/2003 | US6583319 Cyclic compounds having a cycloalkylene chain |
| 06/24/2003 | US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection |
| 06/24/2003 | US6583288 Hydantoin-containing glucokinase activators |
| 06/24/2003 | US6583219 Three-dimensional, crosslinked interpenetrating polymer network |
| 06/24/2003 | US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper |
| 06/24/2003 | US6583172 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| 06/24/2003 | US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one |
| 06/24/2003 | US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents |
| 06/24/2003 | US6583154 Compounds and methods which modulate feeding behavior and related diseases |
| 06/24/2003 | US6583143 CRF receptor antagonists and methods relating thereto |
| 06/24/2003 | US6583141 T cell mediated rheumatic diseases |
| 06/24/2003 | US6583135 Substituted azepino[4,5b]indole derivatives |
| 06/24/2003 | US6583134 Aza- indolyl derivatives for treating obesity |
| 06/24/2003 | US6583126 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
| 06/24/2003 | US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids |
| 06/24/2003 | US6582735 Compositions and methods of use for extracts of magnoliaceae plants |
| 06/24/2003 | US6582721 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 06/19/2003 | WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 06/19/2003 | WO2003050281A2 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity |
| 06/19/2003 | WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 06/19/2003 | WO2003050115A1 Rosiglitazone citrate and its use as antidiabetic |
| 06/19/2003 | WO2003050114A1 Sulfate salt of a thiazolidinedione derivative |
| 06/19/2003 | WO2003050113A1 Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione |
| 06/19/2003 | WO2003050112A1 Toluenesulfonate hydrates of a thiazolidinedione derivative |
| 06/19/2003 | WO2003050111A1 Toluenesulfonate salts of a thiazolidinedione derivative |
| 06/19/2003 | WO2003050097A1 Sodium salt of benzyl thiazolidine-2,4-dione derivative and hydrate thereof |
| 06/19/2003 | WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents |
| 06/19/2003 | WO2003050085A1 CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-HEPTANOIC ACID CALCIUM SALT (2:1) |
| 06/19/2003 | WO2003050077A1 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
| 06/19/2003 | WO2003050067A2 Vitamin d analogues |
| 06/19/2003 | WO2003050066A1 Functionalized higher diamondoids |
| 06/19/2003 | WO2003049759A1 Agonists and antagonists of oxifan for the treatment of metabolic disorders |
| 06/19/2003 | WO2003049758A1 Emergen agonists and antagonists for use in the treatment of metabolic disorders |
| 06/19/2003 | WO2003049757A1 Agonists and antagonists of glucomin for the treatment of metabolic disorders |
| 06/19/2003 | WO2003049756A1 Glucomin agonists and antagonists for use in the treatment of metabolic disorders |
| 06/19/2003 | WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 06/19/2003 | WO2003049748A1 Pharmaceutical and foodstuff products comprising deuterium for the treatment of diabetes and methods for production thereof |
| 06/19/2003 | WO2003049745A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 06/19/2003 | WO2003049742A1 Method for administering birb 796 bs |
| 06/19/2003 | WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 06/19/2003 | WO2003049730A1 Treatment of statin side effects using uridine derivatives |
| 06/19/2003 | WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 06/19/2003 | WO2003049702A2 Vanilloid receptor ligands and their use in treatments |
| 06/19/2003 | WO2003049692A2 The use of acyl salicylates as heat shock inducers |
| 06/19/2003 | WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/19/2003 | WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators |
| 06/19/2003 | WO2003013438A3 Nutrient therapy for immuno-compromised patients |
| 06/19/2003 | WO2003009777A3 Delivery of therapeutic capable agents |
| 06/19/2003 | WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 06/19/2003 | WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/19/2003 | WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same |
| 06/19/2003 | WO2001091696A8 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 06/19/2003 | WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 06/19/2003 | US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 06/19/2003 | US20030114681 C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 06/19/2003 | US20030114678 Cardioprotective phosphonates and malonates |
| 06/19/2003 | US20030114677 Cardioprotective phosphonates and malonates |
| 06/19/2003 | US20030114521 Oxamic acids and derivatives as thyroid receptor ligands |